Saving Democracy with Responsible Parties: A Review Article of Julian E. Zelizer’s In Defense of Partisanship
Political Science Quarterly · 21.08.2026
DOI: 10.1093/psquar/qqag070 ↗Kurz gefasst
Fachartikel in der Zeitschrift Political Science Quarterly, online erschienen am 21.08.2026. Verfasst von Russell Muirhead.
Abstract (Originalsprache)
Partisanship, which is often seen as a disease afflicting American democracy, is actually the cure. This is the core claim of Julian E. Zelizer's compact history of partisanship in the United States, In Defense of Partisanship. Zelizer recovers the twentieth-century tradition of pro-party reform, while breaking with the tradition on a crucial point. Where mid-twentieth -century reformers wanted parties that offered voters a real choice, Zelizer wants partisans who are equally committed to the rivalries that motivate elections and make democracy possible as they are to winning any particular election. This review essay situates Zelizer's argument alongside the structural conditions—insecure majorities and minoritarian institutions—that make his ideal compelling in theory and challenging in practice. It argues that what is ultimately at stake in Zelizer's ideal is the distinction between governing, which modern politics aims at, and rule, which partisans often desire but modern democratic politics tries to do without.
Zitieren
APA
Muirhead, R. (2026). Saving Democracy with Responsible Parties: A Review Article of Julian E. Zelizer’s In Defense of Partisanship. Political Science Quarterly. https://doi.org/10.1093/psquar/qqag070
Vancouver
Muirhead R. Saving Democracy with Responsible Parties: A Review Article of Julian E. Zelizer’s In Defense of Partisanship. Political Science Quarterly. 2026. doi:10.1093/psquar/qqag070
BibTeX
@article{Muirhead2026,
author = {Muirhead, Russell},
title = {Saving Democracy with Responsible Parties: A Review Article of Julian E. Zelizer’s In Defense of Partisanship},
journal = {Political Science Quarterly},
year = {2026},
doi = {10.1093/psquar/qqag070}
}
EUVIMED